Based on the results we conclude that changed expression of miR-493-3p modulates taxol sensitivity in ovarian cancer cell lines via Mad2 depletion, and that high level of miR-493-3p links with poor patient survival in the aggressive forms of ovarian and breast cancer. Here, MAD2L1 is linked to breast carcinoma.